Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-05-31
1997-09-23
Eisenschenk, Frank C.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
424 149, 4241781, 424 153, 424 111, 5303919, C07K 1630, A61K 5100
Patent
active
056706286
ABSTRACT:
Nucleoside thiotriphosphates carrying .sup.32 P in the gamma-thiophosphate group, prepared by reaction between a nucleoside diphosphate and .sup.32 p labelled thiophosphate salt, are used as thiophosphorylating agents for antibodies that bind to tumour-associated antigens. The labelled thiotriphosphates can be used to introduce a therapeutically useful .sup.32 P atom into an antibody that has been modified by the incorporation into its structute of a peptide region capable of acting as a substrate for a phosphokinase. The resulting labelled antibody can then be used for injection in anti-tumour therapy and has clinical advantages over the corresponding phosphoylated analogue.
REFERENCES:
Hoefnagel, 1991, Anti-Cancer Drugs, 2:107.
Kosmas et al., J. Drug Targeting, 1993, 1:81.
Chatterjee, Cancer Immunol. Immunopathol., 1994, 38:75-82.
Curti, Crit. Rev. Oncol. Hematol., 1993, 14:29-39.
Jain, Scientific American, 1994, 271(1):58-65.
Zwierzina, Stem Cells, 1993, 11:144-153.
Band et al. "Radioimmunotargfetting: Thiophosphorylation for enhancing . . . " from Poster presented at 7th Annual International . . . London, May 1990.
Creighton et al. "The development of .sup.32 P technology for radioimmunotherapy" Monoclonal Antibodies 2, Chapman & Hall Medical, 1993, pp. 103-109.
Band et al. ".sup.32 P-labelled antibodies for radioimmunotherapy: a review . . . " Tumor Targeting (1995) 1 pp. 8 5-92.
Cassidy et al "Enzymatic Prepartion . . . " Biochimica et Biophysica Acta, (1979), pp. 209-213.
Walseth et al "The enzymatic preparation of . . ." Biochimica et Biophysica Acta 526 (1979) pp. 11-31.
Eckstein "Phosphorothioate analogues . . . " Accounts of Chem. Research, vol. 12 No. 6 (1979).06).
Cassel et al. 1982 PNAS, 79:2231, Resistance . . . membranes.
Harris et al. 1993 Tibtech, 11:42, Therapeutic . . . Age.
Osband et al, 1990 Immunity Today, 11:193, Problems . . . immunotherapy.
Hird et al, Immunotherapy . . . Antibodies, pp. 183-189, 1990.
Creighton Andrew Malcolm
Foxwell Brian Maurice John
Parker Peter
British Technology Group Ltd.
Eisenschenk Frank C.
LandOfFree
Radio-labelling of proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radio-labelling of proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radio-labelling of proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1939061